Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab with Vismodegib in Basal Cell Nevus Syndrome
NCT03767439Phase 2Withdrawn
- Sponsor
- Columbia University
- Start
- Jul 2019
- Primary completion
- Dec 2019
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of nivolumab in Basal cell nevus syndrome (BCNS), sponsored by Columbia University. Planned start Jul 2019; status: withdrawn.
02
Drugs
03
Conditions
Basal cell nevus syndrome (BCNS)
Beyond the preview
Go deeper on NCT03767439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03767439.